Skip Nav Destination
OnlineFirst
Review September 30 2024
T Cell–Redirecting Bispecific Antibodies in Multiple Myeloma: Optimal Dosing Schedule and Duration of Treatment
Blood Cancer Discov (2024)
In the Spotlight September 30 2024
A Role for Germline Variants in Multiple Myeloma?
Blood Cancer Discov (2024)
Research Article September 16 2024
Multiple Myeloma Risk and Outcomes are Associated with Pathogenic Germline Variants in DNA Repair Genes
Santiago Thibaud; Ryan L. Subaran; Scott Newman; Alessandro Lagana; David T. Melnekoff; Saoirse Bodnar; Meghana Ram; Zachry Soens; William Genthe; Tehilla Brander; Tarek H. Mouhieddine; Oliver Van Oekelen; Jane Houldsworth; Hearn Jay. Cho; Shambavi Richard; Joshua Richter; Cesar Rodriguez; Adriana Rossi; Larysa Sanchez; Ajai Chari; Erin Moshier; Sundar Jagannath; Samir Parekh; Kenan Onel
Blood Cancer Discov (2024)
Research Article September 5 2024
Tracking rare single donor and recipient immune and leukemia cells after allogeneic hematopoietic cell transplantation using mitochondrial DNA mutations
Livius Penter; Nicoletta Cieri; Katie Maurer; Marwan Kwok; Haoxiang Lyu; Wesley S. Lu; Giacomo Oliveira; Satyen H. Gohil; Ignaty Leshchiner; Caleb A. Lareau; Leif S. Ludwig; Donna S. Neuberg; Haesook T. Kim; Shuqiang Li; Lars Bullinger; Jerome Ritz; Gad Getz; Jacqueline S. Garcia; Robert J. Soiffer; Kenneth J. Livak; Catherine J. Wu
Blood Cancer Discov (2024)
Research Brief August 5 2024
Repurposing NAMPT inhibitors for germinal center B-cell-like diffuse large B-cell lymphoma
Claudio Scuoppo; Bowen Cai; Kenneth Ofori; Hanna Scholze; Rahul Kumar; Angelo D'Alessandro; Katia Basso; Laura Pasqualucci; Riccardo Dalla-Favera
Blood Cancer Discov (2024)
Advertisement
RSS Feeds